Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Platelet-rich  plasma (PRP), also called platelet enriched plasma or platelet gel, is a blood plasma product, which contains elevated level of platelets and growth factors (at least four to ten times) than normal blood concentration. An increased blood plasma concentration accentuates the injury healing process by releasing high amount of growth factors at the injury site.

Statistics:

The global platelet-rich plasma market is estimated to account for US$ 352.8 Mn in terms of value in 2020 and is expected to reach US$ 780.8 Mn by the end of 2027.

Global Platelet-rich Plasma Market: Drivers

Increase in cosmetic surgeries is expected to propel growth of the global platelet-rich plasma market over the forecast period. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS) approximately 1,036,618 cosmetic procedures were carried out in Mexico and nearly 128,398 procedures in Thailand in 2018.

Moreover, high prevalence of sports injuries is also expected to aid in growth of the global platelet-rich plasma market over the forecast period. For instance, according to the National High School Sports-Related Injury Surveillance Study 2017-2018, 1,367,490 cases of sport-related were recorded in high schools in the U.S.

Statistics:

Pure PRP held dominant position in the global platelet-rich plasma market in 2019, accounting for 40.9% share in terms of value, followed by Leukocyte rich PRP and Pure PRF, respectively.

Figure 1. Global Platelet-rich Plasma Market Share (%), by Value, by Type, 2019

Platelet Rich Plasma  | Coherent Market Insights

Global Platelet-rich Plasma Market: Restraints

Uncertainty about therapeutic efficacy of platelet-rich plasma is expected to hinder growth of the global platelet-rich plasma market. For instance, the study ‘Current Clinical Recommendations for Use of Platelet-Rich Plasma’ published in Current Reviews in Musculoskeletal Medicine in 2018, found moderate high-quality evidence that supported the use of leukocyte-rich (LR)-PRP injection for patellar tendinopathy and of PRP injection for plantar fasciitis and donor site pain in patellar tendon graft Bone-patellar tendon-bone anterior cruciate ligament reconstruction. Moreover, the review also noted insufficient evidence to routinely recommend PRP for rotator cuff tendinopathy, osteoarthritis of the hip, or high ankle sprains.

Moreover, high cost of platelet-rich plasma products is also expected to hinder growth of the market. The average price of platelet-rich plasma injections starts from US$ 200 to US$ 800, based on its application areas. In addition, treatment of chronic diseases/injuries requires minimum three to six injections, which increases the overall cost of the treatment. Similarly, the average price of platelet-rich plasma centrifuge is around US$ 2,000 to US$ 15,000 (varies according to capacity and other parameters) and Platelet-rich plasma kit is around US$ 25 to US$ 200 (single use kit).

request-sample

Platelet-rich Plasma Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 352.8 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 12.0% 2027 Value Projection: US$ 780.8 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: South Africa, North Africa, Central Africa
Segments covered:
  • By Type: Pure PRP, Leukocyte rich PRP, Pure PRF, Leukocyte rich PRF.
  • By Origin: Autologous, Allogenic, Homologues.
  • By Application: Neurosurgery, Cosmetic Surgery, Orthopedic Surgery, General Surgery, Others.
Companies covered:

Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, and Estar Technologies Ltd.

Growth Drivers:
  • Technological advancement
  • Increasing prevalence of chronic diseases
Restraints & Challenges:
  • Uncertainty about therapeutic efficacy of platelet-rich plasma

Global Platelet-rich Plasma Market: Opportunities 

R&D in drug delivery system for platelet-rich plasma-derived bioactive molecules is expected to offer lucrative growth opportunities for players in the global Platelet-rich plasma market. For instance, in September 2020, researchers from Institute of Experimental Medicine of the Czech Academy of Sciences and Charles University, Czech Republic, reported development of a simple delivery system to prolong the effects of the bioactive molecules released from platelets.

Moreover, high prevalence of musculoskeletal injuries is also expected to boost growth of the global platelet-rich plasma market. For instance, according to the Study, ‘Prevalence of Musculoskeletal Injuries, Pain, and Illnesses in Elite Female Basketball Players, in Europe, in June 2019, the most frequently injured body parts were lower limbs: more than 60%, representing an injury rate of 0.14 per athletes and a 0.2 pain rate per athlete (during the study period).

The global platelet-rich plasma market was valued at US$ 314.6 Mn in 2019 and is forecast to reach a value of US$ 780.8 Mn by 2027 at a CAGR of 12.0% between 2020 and 2027.

Figure 2. Global Platelet-rich Plasma Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Platelet Rich Plasma  | Coherent Market Insights

Market Trends/Key Takeaways

High prevalence of alopecia is expected to boost growth of the global platelet-rich plasma market. For instance, according to a 2019 survey released by the China Association of Health Promotion and Education (CAHEP), one out of six Chinese people, or about 250 million people, are suffering from hair loss.

Moreover, increasing adoption of platelet-rich plasma in cosmetic surgery is also expected to boost growth of the global Platelet-rich plasma market. For instance, according to the American Society of Plastic Surgeons (ASPS) reports platelet-rich plasma (PRP) treatment is estimated to increase by 12% from nearly 113,356 procedures in 2017 to approximately 127,394 procedures in 2018.

Global Platelet-rich Plasma Market: Competitive Landscape

Major players operating in the global platelet-rich plasma market include, Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, and Estar Technologies Ltd.

Global Platelet-rich Plasma Market: Key Developments

Major players in the global platelet-rich plasma market are focused on adopting partnership and collaboration strategies to enhance their market share. For instance, in March 2019, CollPlant, a regenerative medicine company, renewed its exclusive distribution agreement with Arthrex for Vergenix STR, an injectable gel comprised of cross-linked bioengineered recombinant human type I collagen, rhCollagen, combined with autologous platelet-rich plasma, for the treatment of tendinopathy.

Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its wide application and no side effects. Platelet rich plasma is used for the treatment of injured tendons, muscle, joints, and ligaments. Use of PRP therapy on patients with low back pain helps them to recover. It is also widely used for the treatment for baldness, as PRP treatment increase the blood flow. In turn supporting the hair growth.

Restraints of the Global Platelet Rich Plasma Market

Major factors hampering the growth of the platelet rich plasma market during the forecast period constitutes of uncertainty about therapeutic efficacy of platelet-rich plasma.

Key features of the study:

  • This report provides in-depth analysis of the global platelet rich plasma market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global platelet rich plasma market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, and Estar Technologies Ltd
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global platelet rich plasma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Platelet Rich Plasma Market, By Type:
    • Pure PRP
    • Leukocyte rich PRP
    • Pure PRF
    • Leukocyte rich PRF
  • Global Platelet Rich Plasma Market, By Origin:
    • Autologous
    • Allogenic
    • Homologues
  • Global Platelet Rich Plasma Market, By Application:
    • Neurosurgery
    • Cosmetic Surgery
    • Orthopedic Surgery
    • General Surgery
    • Others
  • Global Platelet Rich Plasma Market, By Geography:
    • North America
      • By Type
        • Pure PRP
        • Leukocyte rich PRP
        • Pure PRF
        • Leukocyte rich PRF
      • By Origin
        • Autologous
        • Allogenic
        • Homologues
      • By Application
        • Neurosurgery
        • Cosmetic Surgery
        • Orthopedic Surgery
        • General Surgery
        • Others
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Type
        • Pure PRP
        • Leukocyte rich PRP
        • Pure PRF
        • Leukocyte rich PRF
      • By Origin
        • Autologous
        • Allogenic
        • Homologues
      • By Application
        • Neurosurgery
        • Cosmetic Surgery
        • Orthopedic Surgery
        • General Surgery
        • Others
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Type
        • Pure PRP
        • Leukocyte rich PRP
        • Pure PRF
        • Leukocyte rich PRF
      • By Origin
        • Autologous
        • Allogenic
        • Homologues
      • By Application
        • Neurosurgery
        • Cosmetic Surgery
        • Orthopedic Surgery
        • General Surgery
        • Others
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Type
        • Pure PRP
        • Leukocyte rich PRP
        • Pure PRF
        • Leukocyte rich PRF
      • By Origin
        • Autologous
        • Allogenic
        • Homologues
      • By Application
        • Neurosurgery
        • Cosmetic Surgery
        • Orthopedic Surgery
        • General Surgery
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East:
      • By Type
        • Pure PRP
        • Leukocyte rich PRP
        • Pure PRF
        • Leukocyte rich PRF
      • By Origin
        • Autologous
        • Allogenic
        • Homologues
      • By Application
        • Neurosurgery
        • Cosmetic Surgery
        • Orthopedic Surgery
        • General Surgery
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Type
        • Pure PRP
        • Leukocyte rich PRP
        • Pure PRF
        • Leukocyte rich PRF
      • By Origin
        • Autologous
        • Allogenic
        • Homologues
      • By Application
        • Neurosurgery
        • Cosmetic Surgery
        • Orthopedic Surgery
        • General Surgery
        • Others
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Arthrex, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Stryker Corporation
    • Johnson and Johnsons Ltd.
    • Zimmer Biomet Holdings Inc.
    • Terumo Corporation
    • Glofinn Oy
    • Medira Ltd.
    • Regen Lab S.A.
    • CollPlant
    • Generex Biotechnology Corporation
    • Estar Technologies Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Type
      • Market Snippet, By Origin
      • Market Snippet, By Application
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
    • COVID-19 Impact Analysis
  4. Global Platelet Rich Plasma Market, By Type, 2016 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Pure PRP
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Leukocyte rich PRP
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Pure PRF
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Leukocyte rich PRF
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
  5. Global Platelet Rich Plasma Market, By Origin, 2016 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Autologous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Allogenic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Homologues
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Platelet Rich Plasma Market, By Application, 2016 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Neurosurgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cosmetic Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Orthopedic Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • General Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Platelet Rich Plasma Market, By Regions, 2016 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Company Profiles
      • Arthrex, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Stryker Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Johnson and Johnsons Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Zimmer Biomet Holdings Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Terumo Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Glofinn Oy
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Medira Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Regen Lab S.A
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies.
      • CollPlant
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Generex Biotechnology Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Estar Technologies Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 24 figures on “Platelet Rich Plasma Market – Global forecast to 2027.

Frequently Asked Questions

The global platelet-rich plasma market was valued at US$ 314.6 Mn in 2019 and is forecast to reach a value of US$ 780.8 Mn by 2027 at a CAGR of 12.0% between 2020 and 2027.
Major factor driving the growth of global platelet rich plasma market during the forecast period include technological advancement, and increasing prevalence of chronic diseases.
Major factors hampering the growth of the platelet rich plasma market during the forecast period constitutes of uncertainty about therapeutic efficacy of platelet-rich plasma.
Pure PRP held dominant position in the global platelet rich plasma market in 2019.
North America Platelet Rich Plasma market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, and Estar Technologies Ltd.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner